肝硬化急性肾损伤:基线血清肌酐预测患者结局
北美终末期肝病研究联盟前瞻性纳入653例非择期住院肝硬化患者,按基线血清肌酐分为≤0.5、0.51-1.0、1.01-1.5、>1.5 mg/dl四组。基线血清肌酐较高者更易发生急性肾损伤、进展性病程且30天生存率降低。急性肾损伤期间血清肌酐变化值0.70 mg/dl预测30天死亡的敏感度为68%、特异度为80%。
要点
- 住院肝硬化患者急性肾损伤发生率为47%。
- 基线血清肌酐较高者急性肾损伤发生率更高、30天生存率更低。
- 急性肾损伤期间血清肌酐变化值是影响结局和生存的最强因素。
核心结论
- 住院肝硬化患者基线血清肌酐较高者院内发生急性肾损伤的风险更高,更易出现急性肾损伤进展且生存率降低。
- 作者认为此类患者应密切监测并及时治疗急性肾损伤。
研究设计与样本
- 北美终末期肝病研究联盟为三级肝病中心联盟,前瞻性纳入非择期住院肝硬化患者。
- 按基线血清肌酐水平分为≤0.5、0.51-1.0、1.01-1.5、>1.5 mg/dl四组,评估急性肾损伤发生、结局及30天生存。
- 共纳入653例住院肝硬化患者,年龄56.7±10岁,男性64%,30%合并感染。
主要发现
- 入组患者急性肾损伤发生率为47%。
- 基线血清肌酐较高组更易发生急性肾损伤,其血清肌酐变化值和峰值显著更高(P<0.001),更易呈进展性急性肾损伤病程(P<0.0001),并与30天生存率显著降低相关(P<0.0001)。
- 多因素logistic回归显示,急性肾损伤期间血清肌酐变化值是影响急性肾损伤结局和生存的最强因素(P<0.001)。
- 血清肌酐变化值0.70 mg/dl预测30天死亡的敏感度为68%、特异度为80%。
关键数值与推荐
- 国际腹水俱乐部(IAC)将肝硬化1期急性肾损伤定义为血清肌酐在48小时内较3个月内稳定值急性升高≥0.3 mg/dl或≥50%。
临床怎么用
- 作者认为基线血清肌酐较高的住院肝硬化患者应密切监测并及时治疗急性肾损伤。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The International Ascites Club (IAC) recently defined Stage 1 acute kidney injury (AKI) for cirrhosis as an acute increase in serum creatinine (SCr) by ≥0.3 mg/dl or by ≥50% in <48 h from a stable value within 3 months. The baseline SCr may influence AKI risk and patient outcomes. The objective of this study is to determine in cirrhosis whether the baseline SCr has any effect on the in-hospital AKI course and patient survival. METHODS: North American Consortium for the Study of End-Stage Liver Disease is a consortium of tertiary-care hepatology centers prospectively enroling non-elective cirrhotic inpatients. Patients with different baseline SCr levels (≤0.5, 0.51-1.0, 1.01-1.5, >1.5 mg/dl) were evaluated for the development of AKI, and compared for AKI outcomes and 30-day survival. RESULTS: 653 hospitalized cirrhotics (56.7±10years, 64% men, 30% with infection) were included. The incidence of AKI was 47% of enrolled patients. Patients with higher baseline SCr were more likely to develop AKI, with significantly higher delta and peak SCr (P<0.001) than the other groups, more likely to have a progressive AKI course (P<0.0001), associated with a significantly reduced 30-day survival (P<0.0001). Multivariate logistic regression showed that the delta SCr during an AKI episode to be the strongest factor impacting AKI outcomes and survival (P<0.001), with a delta SCr of 0.70 mg/dl having a 68% sensitivity and 80% specificity for predicting 30-day mortality. CONCLUSIONS: Admitted cirrhotic patients with higher baseline SCr are at higher risk for in-hospital development of AKI, and more likely to have AKI progression with reduced survival. Therefore, such patients should be closely monitored and treated promptly for their AKI.
引用
- Wong F, O'Leary JG, Reddy KR, et al. Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes. Am J Gastroenterol. 2017. PMID: 28440305. doi:10.1038/ajg.2017.122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。